Clinical Significance of miR-766-3p in Severe Pneumonia in Children and Its Associated Molecular Mechanisms
International Archives of Allergy and Immunology · 15.07.2026 · 1-12
DOI: 10.1159/000552583 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Archives of Allergy and Immunology, online erschienen am 15.07.2026. Verfasst von Weili Guo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Emergency Department (Pre-Hospital Emergency), Hebei Children's Hospital, Shijiazhuang, China. Die Arbeit nennt 34 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
Severe pneumonia in children is a critical cause of childhood mortality. miR-766-3p is a known anti-inflammatory factor. The aim of our study is to investigate the clinical value of miR-766-3p and the molecular mechanisms by which miR-766-3p regulates severe pneumonia.
Methods
The relative levels of miR-766-3p in participants’ plasma were detected by quantitative real-time PCR (RT-qPCR). The diagnostic performance and prognostic value of miR-766-3p were assessed using receiver operating characteristic (ROC) curves, Kaplan-Meier curves, and Cox regression models. In vitro, lipopolysaccharide (LPS) was employed to mimic the pneumonia environment. Cell viability was tested by Cell Counting Kit-8 (CCK-8) assay. The levels of inflammatory factor were measured via RT-qPCR and enzyme-linked immunosorbent assay (ELISA).
Results
The levels of miR-766-3p were decreased by 0.36-fold in children with severe pneumonia, and it effectively distinguished between children with severe pneumonia and healthy children. In pediatric patients, the accumulative survival rate was lower in low miR-766-3p expression group (average miR-766-3p level ≤ 0.65) compared to high expression group (average miR-766-3p level > 0.65). Multivariable Cox proportional-hazards regression model analysis indicated that miR-766-3p was an independent risk factor for poor patient outcomes. Moreover, miR-766-3p mimic attenuated the inhibition of cell viability and interleukin-10 (IL-10) levels as well as the promotion of levels of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) caused by LPS. These effects were further abolished by Mucin 19 (MUC19) upregulation. Conclusion: miR-766-3p has potential as a diagnostic and prognostic biomarker. Mechanistically, miR-766-3p alleviates LPS-induced inflammation in MRC-5 cells by modulating MUC19.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Emergency Department (Pre-Hospital Emergency), Hebei Children's Hospital, Shijiazhuang, China.
- Hebei Provincial Clinical Research Center for Child Health and Disease, Shijiazhuang, China.
- Infection Department, Hebei Children's Hospital, Shijiazhuang, China.
- Emergency Department (Pre-Hospital Emergency), Hebei Children's Hospital, Shijiazhuang, China, haokuaiidv482@163.com.
- Hebei Provincial Clinical Research Center for Child Health and Disease, Shijiazhuang, China, haokuaiidv482@163.com.
Zitieren
APA
Guo, W., Si, X., Ma, Z., Zhao, J., & Hao, G. (2026). Clinical Significance of miR-766-3p in Severe Pneumonia in Children and Its Associated Molecular Mechanisms. International Archives of Allergy and Immunology, 1-12. https://doi.org/10.1159/000552583
Vancouver
Guo W, Si X, Ma Z, Zhao J, Hao G. Clinical Significance of miR-766-3p in Severe Pneumonia in Children and Its Associated Molecular Mechanisms. International Archives of Allergy and Immunology. 2026:1-12. doi:10.1159/000552583
BibTeX
@article{Guo2026,
author = {Guo, Weili and Si, Xiaoya and Ma, Zheng and Zhao, Jingxiao and Hao, Gailing},
title = {Clinical Significance of miR-766-3p in Severe Pneumonia in Children and Its Associated Molecular Mechanisms},
journal = {International Archives of Allergy and Immunology},
year = {2026},
pages = {1--12},
doi = {10.1159/000552583}
}
EUVIMED